Clinical Trial Update: NG004 in Spinal Cord Injury Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating NG004 for acute spinal cord injury is currently recruiting, sponsored by NovaGo Therapeutics AG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• NG004

Snippet

Sponsor: NovaGo Therapeutics AG | Conditions: Acute Spinal Cord Injury (SCI), Spinal Cord Diseases | Phase 1 | Status: RECRUITING